|
1
|
D’Amico G: The commonest
glomerulonephritis in the world: IgA nephropathy. Q J Med.
64:709–727. 1987.PubMed/NCBI
|
|
2
|
Appel GB and Waldman M: The IgA
nephropathy treatment dilemma. Kidney Int. 69:1939–1944. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barratt J and Feehally J: IgA nephropathy.
J Am Soc Nephrol. 16:2088–2097. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Julian BA and Novak J: IgA nephropathy: an
update. Curr Opin Nephrol Hypertens. 13:171–179. 2004. View Article : Google Scholar
|
|
5
|
Lai KN: Pathogenesis of IgA nephropathy.
Nat Rev Nephrol. 8:275–283. 2012. View Article : Google Scholar
|
|
6
|
Suzuki H, Suzuki Y, Narita I, et al:
Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc
Nephrol. 19:2384–2395. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goto T, Bandoh N, Yoshizaki T, et al:
Increase in B-cell-activation factor (BAFF) and IFN-gamma
productions by tonsillar mononuclear cells stimulated with
deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in
patients with IgA nephropathy. Clin Immunol. 126:260–269. 2008.
View Article : Google Scholar
|
|
8
|
Suzuki S, Fujieda H, Sunaga H, et al:
Immune response of tonsillar lymphocytes to Haemophilus
parainfluenzae in patients with IgA nephropathy. Clin Exp
Immunol. 119:328–332. 2000. View Article : Google Scholar
|
|
9
|
Fujieda S, Suzuki H, Sunaga, et al:
Induction of IgA against Haemophilus parainfluenzae antigens
in tonsillar mononuclear cells from patients with IgA nephropathy.
Clin Immunol. 95:235–243. 2000.
|
|
10
|
McCluskie MJ, Weeratna RD and Davis HL:
Intranasal immunization of mice with CpG DNA induces strong
systemic and mucosal responses that are influenced by other mucosal
adjuvants and antigen distribution. Mol Med. 6:867–877. 2000.
|
|
11
|
Kajiyama T, Suzuki Y, Kihara M, et al:
Different pathological roles of toll-like receptor 9 on mucosal B
cells and dendritic cells in murine IgA nephropathy. Clin Dev
Immunol. 2011:8196462011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Peng Y, Liu F, Xiao W, Zhang Y and
Li W: Expression of IgA class switching gene in tonsillar
mononuclear cells in patients with IgA nephropathy. Inflamm Res.
60:869–878. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krieg AM and Vollmer J: Toll-like
receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Immunol Rev. 220:251–269. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krieg AM, Yi AK, Matson S, et al: CpG
motifs in bacterial DNA trigger direct B-cell activation. Nature.
374:546–549. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaisho T and Akira S: Dendritic-cell
function in Toll-like receptor- and MyD88-knockout mice. Trends
Immunol. 22:78–83. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ashkar AA and Rosenthal KL: Toll-like
receptor 9, CpG DNA and innate immunity. Curr Mol Med. 2:545–556.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leadbetter EA, Rifkin IR and
Marshak-Rothstein A: Toll-like receptors and activation of
autoreactive B cells. Curr Dir Autoimmun. 6:105–122. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schneider P, MacKay F, Steiner V, et al:
BAFF, a novel ligand of the tumor necrosis factor family,
stimulates B cell growth. J Exp Med. 189:1747–1756. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moore PA, Belvedere O, Orr A, et al: BLyS:
member of the tumor necrosis factor family and B lymphocyte
stimulator. Science. 285:260–263. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Craxton A, Magaletti D, Ryan EJ and Clark
EA: Macrophage- and dendritic cell - dependent regulation of human
B-cell proliferation requires the TNF family ligand BAFF. Blood.
101:4464–4471. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Scapini P, Nardelli B, Nadali G, Calzetti
F, Pizzolo G, Montecucco C and Cassatella MA: A G-CSF-stimulated
neutrophils are a prominent source of functional BLyS. J Exp Med.
197:297–302. 2003.PubMed/NCBI
|
|
22
|
Nardelli B, Belvedere O, Roschke V, et al:
Synthesis and release of B-lymphocyte stimulator from myeloid
cells. Blood. 97:198–204. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bergamin F, Vincent IE, Summerfield A and
McCullough KC: Essential role of antigen-presenting cell-derived
BAFF for antibody responses. Eur J Immunol. 37:3122–3130. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jego G, Pascual V, Palucka AK and
Banchereau J: Dendritic cells control B cell growth and
differentiation. Curr Dir Autoimmun. 8:124–139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Litinskiy MB, Nardelli B, Hilbert DM, He
B, Schaffer A, Casali P and Cerutti A: DCs induce CD40-independent
immunoglobulin class switching through BLyS and APRIL. Nat Immunol.
3:822–829. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
McCarthy DD, Chiu S, Gao Y, Summers-deLuca
LE and Gommerman JL: BAFF induces a hyper-IgA syndrome in the
intestinal lamina propria concomitant with IgA deposition in the
kidney independent of LIGHT. Cell Immunol. 241:85–94. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xin G, Shi W, Xu LX, Su Y, Yan LJ and Li
KS: Serum BAFF is elevated in patients with IgA nephropathy and
associated with clinical and histopathological features. J Nephrol.
26:683–690. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang H, Peng Y, Liu H, Yang X and Liu F:
Decreased CD4+CD25+ cells and increased
dimeric IgA-producing cells in tonsils in IgA nephropathy. J
Nephrol. 23:202–209. 2010.
|
|
29
|
Pontarollo RA, Rankin R, Babiuk LA, et al:
Monocytes are required for optimum in vitro stimulation of bovine
peripheral blood mononuclear cells by non-methylated CpG motifs.
Vet Immunol Immunopathol. 84:43–59. 2002. View Article : Google Scholar
|
|
30
|
Fujieda S, Suzuki S, Sunaga H, Yamamoto H,
Seki M, Sugimoto H and Saito H: Production of interferon-gamma by
tonsillar mononuclear cells in IgA nephropathy patients. Acta
Otolaryngol. 120:649–654. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Buchanan RM, Popowych Y, Arsic N, et al:
B-cell activating factor (BAFF) promotes CpG ODN-induced B cell
activation and proliferation. Cell Immunol. 271:16–28. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Buchanan R, Popowych Y, Dagenais C, et al:
Interferon-gamma and B-cell activating factor (BAFF) promote bovine
B cell activation independent of TLR9 and T-cell signaling. Vet
Immunol Immunopathol. 145:453–463. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ng LG, Ng CH, Woehl B, et al: BAFF
costimulation of Toll-like receptor-activated B-1 cells. Eur J
Immunol. 36:1837–1846. 2006. View Article : Google Scholar : PubMed/NCBI
|
